Related Experiment Video

Updated: Jun 14, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

Complement-fixing antibodies of lymphogranuloma venereum in mice; their development and response to sulfonamide

M J WALL

    Journal of Immunology (Baltimore, Md. : 1950)
    |March 19, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    ANTIGENS AND ANTIBODIESCOMPLEMENT/fixationLYMPHOGRANULOMA VENEREUM/immunitySULFONAMIDES/effects

    More Related Videos

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice12:04

    The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

    Published on: November 1, 2015

    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens09:57

    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

    Published on: February 14, 2011

    Related Concept Videos

    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...